EyeWorld Weekly, August 21, 2026

➤ 510k clearance for all-in-one cloud and browser-based software solution ➤ Final Medicare pricing for FSYX Ocular Pressure Adjusting Pump ➤ First patients dosed in Phase 1b/2a study of potential long-acting anti-VEGF therapy ➤ Topline data for Phase 3 clinical trial for treatment of wet AMD ➤ ASCRS news and events ➤ EyeWorld article of the week

Comments Off on EyeWorld Weekly, August 21, 2026

EyeWorld Weekly, July 31, 2026

➤ FDA approval for treatment of wet AMD ➤ Patient enrollment complete for 510(k) pivotal study for microshunt ➤ Key findings in using PROSE for NK ➤ Successful End-of-Phase 1 Type B meeting for non-atropine eye drop ➤ Digital journal invites original case report submissions ➤ Company news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, July 31, 2026